Clozapine therapeutic plunge in patient with Parkinson's disease
β Scribed by Paul Greene
- Book ID
- 118558034
- Publisher
- The Lancet
- Year
- 1995
- Tongue
- English
- Weight
- 303 KB
- Volume
- 345
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We present the results obtained using low doses of clozapine (mean dose 26.4 mg at bedtime) in the treatment of noctural akathisia in nine patients with Parkinson's disease for a mean period of 12.5 months. The results were excellent in all the patients. Furthermore, three patients expe
## Abstract Clozapine is an atypical neuroleptic medication that is free of parkinsonian side effects and that has been reported to ameliorate the tremor of Parkinson's disease. We report (with videotape illustration) the dramatic improvement of severe yet classic rest tremors in one elderly nonpsy
## Abstract The clinical efficacy of clozapine, an atypical antipsychotic, in treating levodopaβinduced hallucinations was investigated in five patients with Parkinson's disease under open label conditions. Two patients could not tolerate clozapine, even in doses as low as 12.5β25 mg daily, because